drugset
drugset / Trial / NCT04388878

Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants

NCT04388878 ↗

Phase 1 Completed 84 enrolled Pfizer
RandomizedSequentialTriple-blindBasic science

Summary

The purpose of the study is to evaluate the safety, tolerability, and PK of single escalating doses and multiple escalating doses of PF-07054894.

Timeline

Start
2020-07-27
Primary completion
2022-06-21
Completion
2022-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-07054894 Small molecule — —

Indications

No indication recorded.